116 related articles for article (PubMed ID: 21422689)
1. Primary hepatic peripheral T-cell lymphoma treated with corticosteroid.
Miyashita K; Tomita N; Oshiro H; Matsumoto C; Nakajima Y; Ito S; Matsumoto K; Fujita H; Ishigatsubo Y
Intern Med; 2011; 50(6):617-20. PubMed ID: 21422689
[TBL] [Abstract][Full Text] [Related]
2. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study.
Morita-Fujita M; Katoh D; Shimomura Y; Ishikawa T
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e337-e342. PubMed ID: 31053551
[TBL] [Abstract][Full Text] [Related]
3. Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
Sekiguchi Y; Shirane S; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2015; 8(4):4186-203. PubMed ID: 26097612
[TBL] [Abstract][Full Text] [Related]
4. Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma.
Toji T; Takata K; Sato Y; Miyata-Takata T; Hayashi E; Habara T; Maeda Y; Tanimoto M; Yoshino T
J Clin Pathol; 2015 Aug; 68(8):622-7. PubMed ID: 25935549
[TBL] [Abstract][Full Text] [Related]
5. Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U).
Kitagawa J; Hara T; Tsurumi H; Goto N; Kanemura N; Yoshikawa T; Kasahara S; Yamada T; Sawada M; Takahashi T; Shimizu M; Takami T; Moriwaki H
J Cancer Res Clin Oncol; 2009 Jan; 135(1):53-9. PubMed ID: 18592269
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of characteristics in 4 patients with primary gastric peripheral T-cell lymphoma-not otherwise specified].
Li YY; Yang S; Zhang LN; Fan L; Wang L; Zhang R; Xu J; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1374-7. PubMed ID: 23257436
[TBL] [Abstract][Full Text] [Related]
7. [CD20-positive peripheral T-cell lymphoma, not otherwise specified].
Arai H; Maki K; Tadokoro J; Handa T; Nakamura Y; Tsurumi S; Sasaki K; Mitani K
Rinsho Ketsueki; 2012 Jul; 53(7):705-9. PubMed ID: 22975773
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
[TBL] [Abstract][Full Text] [Related]
9. Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
Pileri A; Pellegrini C; Agostinelli C; Grandi V; Patrizi A; Zinzani PL; Pimpinelli N
Eur J Dermatol; 2017 Feb; 27(1):49-53. PubMed ID: 27873737
[TBL] [Abstract][Full Text] [Related]
10. Cervical presentation of peripheral T-cell lymphoma not otherwise specified.
Misono AS; Lin HW; Lee LN; Ferry JA; Rocco JW
Ear Nose Throat J; 2014 Dec; 93(12):E31-4. PubMed ID: 25531852
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous improvement in a pediatric patient with peripheral T-cell lymphoma.
Kobayashi R; Suzuki D; Hori D; Kishimoto K; Sano H; Nakazawa A; Yasuda K; Kobayashi K
Pediatr Int; 2015 Oct; 57(5):1035-7. PubMed ID: 26508191
[TBL] [Abstract][Full Text] [Related]
12. Sub-acute demyelinating polyradiculoneuropathy as an initial symptom of peripheral T cell lymphoma, not otherwise specified (PTCL-NOS).
Kawanishi K; Ohyama Y; Kanai Y; Hirase T; Tanaka H; Miyatake J; Tatsumi Y; Ashida T; Nakamine H; Matsumura I
Intern Med; 2012; 51(15):2015-20. PubMed ID: 22864129
[TBL] [Abstract][Full Text] [Related]
13. [Perforation in the primary T-cell lymphoma of the small intestine due to effective chemotherapy-a case report].
Ebihara T; Nakata K; Fukunaga M; Ohzato H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1711-3. PubMed ID: 24393897
[TBL] [Abstract][Full Text] [Related]
14. CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
Sekiguchi N; Komatsu M; Ichiyama T; Kobayashi A; Gomi D; Fukushima T; Kobayashi T; Noguchi T; Nakazawa H; Asano N; Ishida F; Koizumi T
J Int Med Res; 2021 Feb; 49(2):300060521996165. PubMed ID: 33641488
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy.
Ohara M; Ozaki K; Ohkubo T; Yamada A; Numasawa Y; Tanaka K; Tomii S; Ishibashi S; Sanjo N; Yokota T
Intern Med; 2018 Feb; 57(4):601-604. PubMed ID: 29269644
[TBL] [Abstract][Full Text] [Related]
16. Peripheral T-cell lymphoma--not otherwise specified.
Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
[TBL] [Abstract][Full Text] [Related]
17. Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma: in combination with the International Prognostic Index.
Goto H; Tsurumi H; Takemura M; Ino-Shimomura Y; Kasahara S; Sawada M; Yamada T; Hara T; Fukuno K; Goto N; Okuno M; Takami T; Seishima M; Moriwaki H
J Cancer Res Clin Oncol; 2005 Feb; 131(2):73-9. PubMed ID: 15503137
[TBL] [Abstract][Full Text] [Related]
18. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
Shibata Y; Hara T; Kasahara S; Yamada T; Sawada M; Mabuchi R; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Kito Y; Goto N; Miyazaki T; Takami T; Takeuchi T; Shimizu M; Tsurumi H
Hematol Oncol; 2017 Jun; 35(2):163-171. PubMed ID: 26449182
[TBL] [Abstract][Full Text] [Related]
19. [Peripheral T-cell lymphoma, not otherwise specified accompanied by central nervous system involvement with features of lymphomatosis cerebri].
Fuseya H; Nakao T; Hashimura M; Horiuchi M; Hayashi Y; Hagihara K; Kanashima H; Okuno T; Fukushima H; Inoue T; Manabe T; Yamane T
Rinsho Ketsueki; 2017; 58(7):760-765. PubMed ID: 28781271
[TBL] [Abstract][Full Text] [Related]
20. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
Salvarani C; Boiardi L; Macchioni P; Rossi F; Tartoni P; Casadei Maldini M; Mancini R; Beltrandi E; Portioli I
Ann Rheum Dis; 1995 Aug; 54(8):640-4. PubMed ID: 7677440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
